These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6682781)
1. Effects of parathyroid hormone or haloperidol-induced catalepsy and nigral GAD activity. Nicoletti F; Clementi G; Patti F; Prato A; De Giorgio RM; Scapagnini U Eur J Pharmacol; 1983 Mar; 88(1):135-6. PubMed ID: 6682781 [No Abstract] [Full Text] [Related]
2. Regional differences in cofactor saturation of glutamate decarboxylase (GAD) in discrete brain nuclei of the rat. Effect of repeated administration of haloperidol on GAD activity in the substantia nigra. Itoh M; Uchimura H Neurochem Res; 1981 Dec; 6(12):1283-9. PubMed ID: 7339506 [No Abstract] [Full Text] [Related]
3. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity. Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172 [No Abstract] [Full Text] [Related]
4. Effects of different doses of apomorphine on GAD activity in rat substantia nigra. Condorelli DF; Giammona G; Patti F; Nicoletti F; Rampello L; Reggio A; Matera M; Di Giorgio RM Ital J Neurol Sci; 1981 Aug; 2(3):303-6. PubMed ID: 7341553 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of glutamate decarboxylase in the substantia nigra of the rat. Ribak CE; Vaughn JE; Saito K; Barber R Res Publ Assoc Res Nerv Ment Dis; 1976; 55():205-11. PubMed ID: 1005902 [No Abstract] [Full Text] [Related]
6. Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Ribak CE; Vaughn JE; Saito K; Barber R; Roberts E Brain Res; 1976 Nov; 116(2):287-98. PubMed ID: 788859 [TBL] [Abstract][Full Text] [Related]
7. Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Gunne LM; Häggström JE Psychopharmacology (Berl); 1983; 81(3):191-4. PubMed ID: 6139837 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of estrogens and prolactin on nigral and striatal GAD activity. Nicoletti F; Patti F; Ferrara N; Canonico PL; Giammona G; Condorelli DF; Scapagnini U Brain Res; 1982 Jan; 232(1):238-41. PubMed ID: 7055706 [TBL] [Abstract][Full Text] [Related]
9. Effect of haloperidol on glutamate decarboxylase activity in discrete brain areas of the rat. Itoh M Psychopharmacology (Berl); 1983; 79(2-3):169-72. PubMed ID: 6405424 [TBL] [Abstract][Full Text] [Related]
10. Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra. Kim JS; Hassler R Brain Res; 1975 Apr; 88(1):150-3. PubMed ID: 1122395 [No Abstract] [Full Text] [Related]
11. Subcellular fractions of normal human substantia nigra and caudate nucleus; a study of their morphology and some enzymes including glutamate decarboxylase and choline acetyltransferase. Hickey SM; Ansell GB; Mitchell K; Pearce GW J Neurochem; 1976 Oct; 27(4):957-62. PubMed ID: 966028 [No Abstract] [Full Text] [Related]
12. Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Fonnum F; Gottesfeld Z; Grofova I Brain Res; 1978 Mar; 143(1):125-38. PubMed ID: 630396 [No Abstract] [Full Text] [Related]
13. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents]. Vamvakidès A Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324 [No Abstract] [Full Text] [Related]
14. Glutamate decarboxylase (GAD) and gamma-aminobutyric acid (GABA) in discrete nuclei of hypothalamus and substantia nigra. Tappaz ML; Brownstein MJ; Kopin IJ Brain Res; 1977 Apr; 125(1):109-21. PubMed ID: 856403 [TBL] [Abstract][Full Text] [Related]
15. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy. Morelli M; Porceddu ML; Imperato A; Di Chiara G Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799 [TBL] [Abstract][Full Text] [Related]
16. Sulpiride effects on nigral and striatal glutamic acid decarboxylase activity: a possible involvement of prolactin. Nicoletti F; Canonico PL; Patti F; Rampello L; Condorelli DF; giammona G; Di Giorgio RM; Scapagnini U Eur J Pharmacol; 1982 Jan; 77(2-3):131-5. PubMed ID: 7060633 [TBL] [Abstract][Full Text] [Related]
17. [Immunocytochemical localization of GAD and CSAD in the rat cerebellum and spinal cord]. Wu H; Song GX; Liu SD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Oct; 8(5):391-3. PubMed ID: 2952314 [No Abstract] [Full Text] [Related]
18. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480 [TBL] [Abstract][Full Text] [Related]
19. Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum. Oertel WH; Schmechel DE; Brownstein MJ; Tappaz ML; Ransom DH; Kopin IJ J Histochem Cytochem; 1981 Aug; 29(8):977-80. PubMed ID: 7024401 [TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity. Al-Shabibi UM; Davies JA Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]